Parkinsonism during cyclosporine treatment.
Cyclosporine has been associated with various neurological side-effects including postural tremor, seizures, headaches, encephalopathy, cortical blindness, and visual hallucinations. We describe here two patients who developed parkinsonism, with rest tremor and bradykinesia, after receiving cyclosporin A following allogeneic bone marrow transplantation. The patients did not have pre-existing neurological disorders, and had not received significant amounts of dopamine-blocking drugs. One patient improved markedly with Sinemet (carbidopa-levodopa), while the other (who did not tolerate Sinemet) improved with decrease in cyclosporine dosage. The relation of the parkinsonian symptoms to cyclosporine therapy and lack of other evident causes for the symptoms, suggests that parkinsonism may be an occasional consequence of cyclosporine.
Wasserstein
P H
PH
Dept of Neurology and Neurological Sciences, Stanford University School of Medicine, CA, USA.
Honig
L S
LS
D000328:Adult; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*
D007166:Immunosuppressive Agents; D016572:Cyclosporine